Shares of Day One Biopharmaceuticals, Inc. (DAWN) have gained 2.3% over the past four weeks to close the last trading session at $7.04, but there could still be a solid upside left in the stock if ...
Day One Biopharmaceuticals, Inc. (DAWN) closed the last trading session at $11.16, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results